Literature DB >> 16273018

Cognitive-behavioral treatment of irritable bowel syndrome.

Brenda B Toner1.   

Abstract

There is increasing evidence that supports the view that irritable bowel disorder (IBS) is a disorder of brain-gut function. Cognitive-behavioral therapy (CBT) has received increased attention in light of this recent shift in the conceptualization of IBS. This review has two main aims. The first is to provide a critical review of controlled trials on CBT for IBS. The second is to discuss ways of further developing CBT interventions that are more clinically relevant and meaningful to health care providers and individuals with a diagnosis of IBS. A theme from a CBT intervention will be presented to illustrate how CBT interventions can be incorporated within a larger social context. A review of CBT for IBS lends some limited support for improvement in some IBS symptoms and associated psychosocial distress. This conclusion needs to be expressed with some caution, however, in light of many methodological shortcomings including small sample sizes, inadequate control conditions and failure to identify primary versus secondary outcome measures. In addition, future studies will need to further develop more relevant CBT protocols that more fully integrate the patient's perspective and challenge social cognitions about this stigmatized disorder.

Entities:  

Mesh:

Year:  2005        PMID: 16273018     DOI: 10.1017/s1092852900019854

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

Review 1.  Psychological approach to managing irritable bowel syndrome.

Authors:  Bu'Hussain Hayee; Ian Forgacs
Journal:  BMJ       Date:  2007-05-26

2.  Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.

Authors:  Shiv Gautam
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

3.  How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial.

Authors:  Jeffrey M Lackner; James Jaccard; Susan S Krasner; Leonard A Katz; Gregory D Gudleski; Edward B Blanchard
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

Review 4.  IBS and the role of otilonium bromide.

Authors:  Guy Boeckxstaens; Enrico S Corazziari; Fermín Mearin; Jan Tack
Journal:  Int J Colorectal Dis       Date:  2012-11-22       Impact factor: 2.571

5.  Psychological distress and impaired quality of life common among community-dwelling adults with lower gastrointestinal disorders.

Authors:  Tara W Strine; Daniel P Chapman; Nicole Flowers
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.